In Brief: Guidant:
This article was originally published in The Gray Sheet
Executive Summary
Guidant: Receives FDA go-ahead to market the ACS RX Comet rapid-exchange coronary dilation catheter for percutaneous transluminal coronary angioplasty (PTCA). The Comet features an "ultra-low profile and sleek design" that allows "easy maneuverability to cross and reach difficult lesions," Guidant says. The device also features P-Flex Plus, an extended balloon pressure material that "widens the variety of inflation choices." U.S. marketing will begin immediately...